Jay Flatley Headshot
Report a problem with this profile
[email protected]

Jay Flatley  

CEO at Illumina

Jay Flatley has served as CEO and as a director of Illumina since October 1999. He drives the strategic vision for the company and manages its commercial and corporate functions. Until December 2013, he served in the dual role of president and CEO leading the company through a period of tremendous growth. With the company’s initial success in genotyping and subsequent expansion into whole-genome sequencing, diagnostics and informatics, sales grew from $1.3 million in 2000 to more than $1.42 billion in 2013. Under Mr. Flatley’s leadership, the company launched over 50 major products, acquired several new technologies and entered multiple markets in the research, applied and clinical arenas. Illumina is now uniquely positioned to unlock the power of the genome, as the leading provider of genetic analysis technologies.

Prior to joining Illumina, Mr. Flatley was co-founder, president, CEO and a director of Molecular Dynamics, Inc., a NASDAQ-listed life sciences company focused on genetic discovery and analysis, from 1994 until its sale to Amersham Pharmacia Biotech Inc. in 1998. He served in various other positions of increasing responsibility with molecular dynamics from 1987 to 1994. From 1985 to 1987, Mr. Flatley was Vice President of Engineering and Vice President of Strategic Planning at Plexus Computers, a UNIX computer company. Mr. Flatley also serves as a director of Coherent, Inc., a NASDAQ-listed provider of photonics-based solutions to commercial and scientific research markets.

Mr. Flatley holds a B.A. in economics from Claremont McKenna College and a B.S. and M.S. in industrial engineering from Stanford University.


No videos yet.


PMWC 2014 Honors Illumina CEO Jay Flatley as Luminary Award ...

PMWC chose to honor Jay Flatley for his dynamic leadership in fueling the advancement of personalized medicine for over 15 years. Jay's vision has helped  ...

Illumina Launches the NextSeq(TM) 500 Sequencing System - WSJ ...

... of the NextSeq 500 System furthers this distinction by enabling next-generation sequencing to become an everyday tool," said Jay Flatley, CEO of Illumina.

Illumina Genome Sequencing Growth - Business Insider

By pretty much any measure, biotechnology company Illumina's growth has been spectacular. When Jay Flatley joined as CEO in 1999, the San Diego-based ...

Illumina's New Low-Cost Genome Machine Will Change Health ...

CEO Jay Flatley at Illumina's San Diego headquarters. Dr. Bradley Patay, who is tanned and handsome, with a constant smile that pushes the limits of cheek ...

Related Speakers View all

More like Jay